https://www.prnewswire.com/news-releases/deadline-reminder-faruqi--faruqi-llp-investigates-claims-on-behalf-of-investors-of-bioage-labs-302351367.html
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BioAge Labs, Inc. ("BioAge" or the...
deadline reminderfaruqillpinvestigatesclaims
https://www.macrotrends.net/stocks/charts/BIOA/bioage-labs/ebitda
BioAge Labs ebitda from 2024 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
bioagelabsebitdamacrotrends
https://www.fiercebiotech.com/biotech/bioage-labs-aims-raise-180m-ipo-private-placement-fund-obesity-trials
Assuming a final share price of $18, the IPO and the private placement should bring in a combined $180.6 million in net proceeds.
private placementbioageeyesipoobesity
https://www.hl.co.uk/shares/shares-search-results/b/bioage-labs-inc-usd0.00001/share-charts
The latest BioAge Labs Inc (BIOA) USD0.00001 share price (BIOA). View recent trades and share price information for BioAge Labs Inc (BIOA) USD0.00001
share pricebioagelabsinc
https://www.stocktitan.net/news/BIOA/bio-age-announces-pricing-of-upsized-115-0-million-public-dn2zuqb2tknr.html
Offering of 5.9M shares at $19.50 is set to bring BioAge $115M before fees, funding BGE-102 and other metabolic aging programs; close expected Jan. 23.
stock offeringbioageprices
https://www.pharmaceutical-technology.com/data-insights/azelaprag-bioage-labs-obesity-likelihood-of-approval/
Azelaprag is under clinical development by BioAge Labs and currently in Phase II for Obesity.
azelapragbioagelabsobesitylikelihood
https://www.globenewswire.com/news-release/2026/01/12/3216965/0/en/BioAge-Announces-Additional-Positive-Interim-Phase-1-Data-for-BGE-102-a-Novel-Brain-Penetrant-NLRP3-Inhibitor-Demonstrating-Potential-for-Best-in-Class-hsCRP-Reduction-in-Participa.html
First BGE-102 MAD cohort completed in obese individuals with elevated hsCRP receiving 120 mg QD; demonstrated rapid and profound reduction in inflammatory...
bioageannouncesadditionalpositiveinterim